FDA Expands Use of Immunotherapeutic to Head and Neck Cancer
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
Category: AACR
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
It’s a familiar tale: Regulatory agencies approve a new cancer treatment, but it comes with an astronomically high price....
Immunotherapy is revolutionizing the treatment of cancer. As discussed in an earlier post on this blog, immunotherapeutics that work...
Michael Caligiuri, MD, director of The Ohio State University Comprehensive Cancer Center and CEO of Arthur G. James Cancer...
Medical journalist Andrew Schorr, a two-time cancer survivor, created Patient Power in 2005 as an online portal for information...
Sarcomas are malignancies of the connective tissues of the body, comprising a diverse collection of different cancers that arise...
Liquid biopsies, noninvasive tests performed on biofluids to detect genetic alterations in tumors, are a recent revolution in the...
Clinical trials are an essential part of cancer research. They ensure that scientific discoveries are translated into advances in...
Guest post by Christine Lovly, MD, PhD We all remember our “firsts” – first pet, first car, first job,...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today In his 2016 State of the Union address, President...